Mary Szela
CEO
CEO
Board Member
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | TriSalus Life Sciences, Inc. (TLSI) | CEO and President | $600,920 | $4,823,349 |
| 2024 | TriSalus Life Sciences, Inc. (TLSI) | CEO and President | $601,398 | $4,136,595 |
| 2023 | TriSalus Life Sciences, Inc. (TLSI) | CEO and President | $518,077 | $2,692,830 |
| 2022 | TriSalus Life Sciences, Inc. (TLSI) | CEO and President | $463,630 | $641,901 |
Executive changes
Earnings-call appearances
-
Canaccord Genuity 46th Annual Growth Conference2026-08-12
TriSalus Life Sciences, Inc. (TLSI)
-
TriSalus Life Sciences Second Quarter 2026 Earnings Call2026-08-06
TriSalus Life Sciences, Inc. (TLSI)
-
TriSalus Life Sciences, Inc. Q1 FY2026 Earnings Call2026-05-12
TriSalus Life Sciences, Inc. (TLSI)
-
TriSalus Life Sciences, Inc. Q4 FY2025 Earnings Call2026-03-05
TriSalus Life Sciences, Inc. (TLSI)
-
TriSalus Life Sciences, Inc. Q3 FY2025 Earnings Call2025-11-13
TriSalus Life Sciences, Inc. (TLSI)
-
TriSalus Life Sciences, Inc. Q2 FY2025 Earnings Call2025-08-12
TriSalus Life Sciences, Inc. (TLSI)
-
TriSalus Life Sciences, Inc. Q1 FY2025 Earnings Call2025-05-15
TriSalus Life Sciences, Inc. (TLSI)
-
TriSalus Life Sciences, Inc. Q3 FY2024 Earnings Call2024-11-14
TriSalus Life Sciences, Inc. (TLSI)
-
TriSalus Life Sciences, Inc. Q2 FY2024 Earnings Call2024-08-15
TriSalus Life Sciences, Inc. (TLSI)
-
TriSalus Life Sciences, Inc. Q1 FY2024 Earnings Call2024-04-01
TriSalus Life Sciences, Inc. (TLSI)
-
TriSalus Life Sciences, Inc. Q4 FY2023 Earnings Call2024-03-12
TriSalus Life Sciences, Inc. (TLSI)
-
TriSalus Life Sciences, Inc. Q3 FY2023 Earnings Call2023-11-14
TriSalus Life Sciences, Inc. (TLSI)